**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

 

**FORM 10-Q/A**

 Amendment No. 1 

 

| **x** | **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
|-------|---------------------------------------------------------------------------------------------|

 

For the quarterly period ended **June 30, 2019**

 

| ** ̈** | **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
|------------|----------------------------------------------------------------------------------------------|

 

For the transition period from ____________ to ____________

 

**Commission file number: 000-27781**

 

| **UNITED HEALTH PRODUCTS, INC.**                    |
|-----------------------------------------------------|
| (Exact name of Company as specified in its charter) |

 

| **Nevada**                                                     |   | **84-1517723**                       |
|----------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |

 

| **10624 S. Eastern Ave., Suite A209**

**Henderson, NV** |   | **89052**  |
|----------------------------------------------------------|--------|------------|
| (Address of Company's principal executive offices)       |   | (Zip Code) |

 

**(877) 358-3444**

(Company's telephone number, including area code)

 

**None**

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

| **Title of each class:** |   | **Trading Symbol(s)** |   | **Name of each exchange on which registered:** |
|--------------------------|--------|-----------------------|--------|------------------------------------------------|
| N/A                      |   | N/A                   |   | N/A                                            |

 

Securities registered pursuant to Section 12(g) of the Act: Common stock, $.001 par value

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 the Securities Act. Yes  ̈No x

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes  ̈No x

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No  ̈

 

Indicate by checkmark whether the registrant has submitted electronically on its corporate website, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the 12 preceding months (or such shorter period that the registrant was required to submit such file). Yes xNo  ̈

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

| Large accelerated filer |  ̈ | Accelerated filer         |  ̈ |
|-------------------------|--------|---------------------------|--------|
| Non-accelerated filer   |  ̈ | Smaller reporting company | x      |
|                         |   | Emerging growth company   |  ̈ |

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ̈

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ̈No x

 

The number of shares issued of the Registrant's Common Stock, as of August 13, 2019 was 176,588,907 issued and outstanding. 

 

|  |
|--|

    

** **

**EXPLANATORY NOTE**

   

 The sole purpose of this Amendment No. 1 to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 of United Health Products, Inc. (the “Company”) filed with the Securities and Exchange Commission on August 14, 2019 (the “Form 10-Q”) is to update the cover page of the Form 10-Q to correct typographical errors. 

   

 No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q. 

   

 
 2
  

 

  

**SIGNATURES**

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this amended report to be signed on its behalf by the undersigned, thereunto duly authorized on August 21, 2019.

 

|   | **United Health Products, Inc.** |                                              |
|--------|----------------------------------|----------------------------------------------|
|        |                                  |                                              |  |
|   | By:                              | */s/ Douglas Beplate*                        |  |
|        |                             | Douglas Beplate

Principal Executive Officer |  |

 

|   | By:    | */s/ Nate Knight*           |  |
|--------|--------|-----------------------------|--|
|        |   | Nate Knight                 |  |
|        |   | Principal Financial Officer |  |

 

  

3